Cargando…
Novel Strategy of Proxalutamide for the Treatment of Prostate Cancer through Coordinated Blockade of Lipogenesis and Androgen Receptor Axis
Objective: Prostate cancer (PCa) is the most common malignant tumor diagnosed in men in developed countries. In developing countries, the PCa morbidity and mortality rates are also increasing rapidly. Since androgen receptor (AR) is a key driver and plays a critical role in the regulation of PCa dev...
Autores principales: | Gu, Yue, Xue, Mengxia, Wang, Qizhi, Hong, Xiaodan, Wang, Xinyu, Zhou, Fang, Sun, Jianguo, Wang, Guangji, Peng, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704202/ https://www.ncbi.nlm.nih.gov/pubmed/34948018 http://dx.doi.org/10.3390/ijms222413222 |
Ejemplares similares
-
Emerging Therapeutic Activity of Davallia formosana on Prostate Cancer Cells through Coordinated Blockade of Lipogenesis and Androgen Receptor Expression
por: Hsieh, Po-Fan, et al.
Publicado: (2020) -
Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response
por: Qiao, Yuanyuan, et al.
Publicado: (2023) -
Proxalutamide for the treatment of COVID‐19 rebound following Paxlovid treatment: Report of four cases and review of the literature
por: Yang, Da‐Wei, et al.
Publicado: (2023) -
Suppression of the Hypothalamic-pituitary-adrenal Axis by Maximum Androgen Blockade in a Patient with Prostate Cancer
por: Kondo, Takeshi, et al.
Publicado: (2016) -
Maximal androgen blockade for advanced prostate cancer
por: Mukha, Rajiv Paul, et al.
Publicado: (2010)